GUIDELINES FOR AUTHORS ON PREPARING MANUSCRIPTS
Click here for a detailed overview on preparing your manuscript, including general
policies, the review process, types of manuscripts published, and guidelines for preparing tables and figures.
The Journal of Neuropsychiatry and Clinical Neurosciences
has implemented a web-based manuscript submission and
tracking system to accelerate the peer review process and shorten the
time from manuscript
submission to publication decision. The Journal will no longer accept manuscripts and letters by mail.
To submit your paper, please visit the manuscript submission site at Manuscript Central
and either create an account or use your existing account. Then
follow the instructions to upload your manuscript. All
submissions must include a title page and be accompanied by a cover
letter and list of suggested
AUTHORSHIP, DISCLOSURE, AND COPYRIGHT TRANSFER FORMS
Please visit the American Psychiatric Publishing (APP), website for forms.
PUBLIC ACCESS POLICY
Broad access to the research literature and the rights of our authors are important to APP, the publisher of The Journal of Neuropsychiatry and Clinical Neurosciences. Read our public access policy for guidelines on deposit mandates
for research funded by NIH and others and institutional repositories.
The National Institutes of Health (NIH) Revised Policy on
Enhancing Public Access to Archived Publications Resulting from
NIH-Funded Research (Public
Access Policy), which took effect on April 7, 2008,
requires all investigators funded by the NIH to submit or have submitted
for them their final
peer-reviewed manuscript upon acceptance for
publication to the National Library of Medicine’s (NLM) PubMed Central
(PMC) to be made publicly available no later than 12 months after the
official date of publication. APP acknowledges that the
Author retains the right to provide a copy of the manuscript to the NIH
upon acceptance for
publication (i.e., after all modifications from the peer
review process but before copyediting, formatting, and production work
performed to produce
the final published article) for public archiving in
PubMed Central. Except for special circumstances in which specific
arrangements have been made,
APP does not deposit manuscripts on behalf of
authors. The NIH has developed a password-protected, web-based NIH Manuscript Submission (NIHMS system to implement the NIH Public Access Policy.
Learn more about APP’s guidelines for research funded by NIH and other funders.
No author reprints are furnished gratis. A reprint order
form will be sent to the corresponding author before publication of the
article. Reprints are
mailed to the corresponding author approximately 6 weeks
after the article has been published. Articles, Book Review Forums, and
Letters to the Editor
can be downloaded by subscribers from the Journal website at ajp.psychiatryonline.org.
Click here for information on ordering bulk reprints for commercial use.
BACK TO TOP
BECOMING A REVIEWER
Individuals interested in reviewing for The Journal of Neuropsychiatry and Clinical Neurosciences should visit Manuscript Central and create an account.
Abstracts of articles within a reviewer’s given area of
expertise are sent via e-mail to the reviewer. Within 3 days, the
reviewer is asked to indicate
willingness to review and availability to perform the
review within a 2-week time frame.
Most competing interests, financial or otherwise, do not
disqualify one from participating in the peer review process, but the Journal requests
that you indicate any conflict that you may have in reviewing any particular manuscript. You can also notify the Journal if you feel that you
cannot review a manuscript because of a competing interest. This will not affect your reviewer status in any way.
Manuscripts must be reviewed with due respect for authors’
confidentiality. In submitting their manuscripts for review, authors
entrust the Journal with the results of their scientific work
and creative effort, on which their reputation and career may depend.
Authors’ rights may be
violated by disclosure of the confidential details of the
review of their manuscript. Reviewers should never copy, share, or
discuss a manuscript under
review or the data within with anyone without expressed
written permission of the Journal’s Editor and the authors.
RECEIVE CME CREDIT FOR REVIEWING
The American Psychiatric Association (APA), in keeping with American Medical Association (AMA) guidelines, offers AMA PRA Category 1 Credit&trade for review of manuscripts submitted to The Journal of Neuropsychiatry and Clinical Neurosciences.
The Editor and Deputy Editors will award credit for reviews submitted on time
that provide a comprehensive and constructive critique of a
manuscript and reveal an extensive knowledge of the
literature and evidence base. A review deemed worthy of CME credit
should not only assist an author
in preparing a revision suitable for publication but also
provide an important educational service to clinicians and investigators
By submitting such a review, participants also will have
improved their own skills by performing critical analysis of the medical
identifying gaps in knowledge, and obtaining new
information to contribute to their research and/or practice.
Once a review has been judged worthy of CME credit, the
reviewer will be notified by the APA Department of CME. An evaluation
will be provided to all
participants in the form of an Impact Survey. Participants will complete the Impact Survey and then indicate the number of credits earned
and check a box to confirm Attestation of Credit. A CME certificate then will be generated by APA and sent to the participant. Up to three AMA PRA Category 1 Credit(s)&trade
per manuscript review may be granted, with up to five reviews per year
(up to 15 credits). The APA
Department of CME will maintain CME records on file for 10
years in keeping with ABPN requirements for recertification.
To be eligible, potential reviewers must complete and submit
to the Journal office an annual disclosure form, available here.
Contact the Editorial Office
The White Label mobile view features a portion of the site's content optimized for the unique size and speed constraints of mobile browsers.
To access this version of the site, you must sign in using your email address and password. If you have not created such a profile, please visit the site on a nonmobile browser, select the "My Stuff" tab, and follow the directions for creation of a profile. Once complete, you may return to the mobile view and use that email address and password to access the site.
The White Label mobile view supports the following mobile operating systems: iOS 1.0 and above, Android 1.0 and above, and Blackberry 6.